$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
What is the general market price of Bedaquiline 24 capsules?
2026-02-01 22:25:32
Check Details
What specific adverse reactions may Dasatinib/Startaxate cause?
2026-02-01 22:25:32
Check Details
Analysis of Anamorelin still showing no effect after 20 days of use
2026-02-01 22:25:32
Check Details
Mitotane: from core drug in the treatment of adrenocortical cancer to future innovation direction
2026-02-01 22:25:32
Check Details
Detailed analysis of the pharmacological effects and mechanisms of decavatinib
2026-02-01 22:25:32
Check Details
Observation on the clinical effect of Apremilast (Otelor) on improving joint function
2026-02-01 22:25:32
Check Details
Possible adverse reactions caused by the combination of Valganciclovir and immunosuppressants
2026-02-01 22:25:32
Check Details
Antibody-conjugated drug combination treatment for Osimertinib (Tagrisso) resistance cases
2026-02-01 22:25:32
Check Details
Instructions on the best medication time and medication intervals for Eltrombopag (Revlan)
2026-02-01 22:25:32
Check Details
Reasons and countermeasures for platelet drop after using up Roprostim (Huierning)
2026-02-01 22:25:32
Check Details
Does Midostaurin cause bone marrow suppression and guidelines for safe use
2026-02-01 22:25:32
Check Details
Detailed description of which diseases and indications Cabergoline is suitable for
2026-02-01 22:25:32
Check Details
1
2
...
2318
2319
2320
2321
2322
2323
2324
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma